SARS-CoV-2 Can Infect Human Brain Organoids

The results are a proof-of-concept that the novel coronavirus can replicate in neurons, but it’s too soon to say whether this occurs in people with COVID-19.

Written byKatarina Zimmer
| 5 min read
organoid human brain sars-cov-2 covid-19 coronavirus pandemic ac2 receptor neurological symptoms central nervous system

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: A brain organoid cultured from human stem cells in which some cells are infected with SARS-CoV-2. Viral protein is stained red, and neuron nuclei labeled in blue.
SONG ET AL.,YALE UNIVERSITY

With no ideal animal model that mimics how SARS-CoV-2 infection leads to COVID-19 in people, several research groups are turning to mini-organs grown from human stem cells to better understand whether and how different organs could become potential targets of infection.

In a preliminary, not-yet-peer-reviewed study posted June 26 to bioRxiv, a team of Yale University researchers report that SARS-CoV-2 is capable of infecting and replicating in neurons in human brain organoid models. While the finding is consistent with two other, smaller studies, there’s no clear evidence so far that the virus can infect brains.

“I think these [organoid] papers are interesting, but it’s too early to know how to put [them] in context of the rest of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies